• Immune Therapeutics to Acquire Aletheia Therapeutics americanpharmaceuticalreview
    December 19, 2019
    Immune Therapeutics and Aletheia Therapeutics announced that Immune will acquire Aletheia in an all-stock transaction. Pursuant to completion of a definitive agreement ...
PharmaSources Customer Service